Taking advantage of sensitivity data from over 4600 drugs tested against 26 different ERα-positive and ERα-negative BC cell lines available in the DepMap portal database (https://depmap.org/portal/), we identified a list of 73 drugs that exhibited increased sensitivity in ERα-positive BC cell lines compared to ERα-negative ones. Here, ESR1 is linked to breast cancer.